Search Results 1061-1070 of 16445 for monoclonal antibody

1. A Study of Obinutuzumab to Evaluate the Safety and Tolerability in Hypersensitized Adult Participants with End Stage Renal Disease Awaiting Transplantation - Mayo Clinic

   ... antibody (HBcAb) or seropositivity ... History of severe allergic or anaphylactic reactions to monoclonal antibodies or components of obinutuzumab infusion ...

2. A Study of Adults 65 Years or Older to Establish Normal Lymphocyte Subsets and Immunoglobulin Levels - Mayo Clinic

   Current or previous treatment with biologics, monoclonal antibodies, or other immunosuppressive treatment (due to possibility of secondary immunodeficiency).

3. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

   History of severe hypersensitivity reaction to any monoclonal antibody. Other severe acute or chronic medical (including bone marrow suppressive diseases) ...

4. Study of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy in Subjects with Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   formulations or history of severe infusion-related reactions to monoclonal antibodies - Any other active malignancy at time of randomization or diagnosis of ...

5. Study of Lenzilumab and Axicabtagene Ciloleucel in Subjects with Relapsed or Refractory Large B-cell Lymphoma - Mayo Clinic

   Subjects must have received adequate prior therapy including at a minimum: Anti-CD20 monoclonal antibody unless investigator determines that tumor is CD20 ...

6. Prostate Cancer Clinical Trials - Mayo Clinic Research

   Pertuzumab and trastuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called human epidermal growth factor ...

7. A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia - Mayo Clinic

   Subject who received any prior monoclonal antibodies against PD-1 or PD-L1 and/or any prior: Arm A only: ImiDs (eg, lenalidomide, thalidomide);; Arm B ...

8. Kidney Transplant Program - ABO incompatible kidney transplant - Mayo Clinic

   In the past, if your blood contained antibodies that reacted to your donor's blood type, the antibody reaction would immediately cause you to reject your ...

9. Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) - Mayo Clinic

   Prior systemic therapy (eg, chemotherapy, immunomodulatory therapy, or monoclonal antibody therapy) within 3 weeks prior or 5 half-lives of the drug, whichever ...

10. Benralizumab for Eosinophilic Esophagitis - Mayo Clinic

    Receipt of any marketed or investigational biologic (monoclonal or polyclonal antibody) within 4 months or 5 half-lives prior to the date informed consent ...